Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells

Oncogene

Volumn 27, Issue 18, 2008, Pages 2575-2582

  Martinez, I ^a   Gardiner, A S ^a   Board, K F ^a   Monzon, F A ^b   Edwards, R P ^c   Khan, S A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cervical cancer; HPVs; microRNA; Oncogene

Indexed keywords

MICRORNA; PROTEIN E6; PROTEIN E7;

ARTICLE; CANCER GENETICS; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; LAMB3 GENE; MOLECULAR GENETICS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS ONCOGENE;

CELL ADHESION MOLECULES; CELL TRANSFORMATION, VIRAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 6; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 42249105032     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210919     Document Type: Article

References (33)

1. Alazawi W, Pett M, Arch B, Scott L, Freeman T, Stanley MA et al. (2002). Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res 62: 6959-6965.
2. Band V, Dalal S, Delmolino L, Androphy EJ. (1993). Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J 12: 1847-1852.
3. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N et al. (2006). Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29-38.
4. Calaluce R, Bearss DJ, Barrera J, Zhao Y, Han H, Beck SK et al. (2004). Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia 6: 468-479.
5. Calin GA, Croce CM. (2006). MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390-7394.
6. Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND. (2006). Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80: 8940-8950.
7. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz Jr LA, Sjoblom T et al. (2006). The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687-3692.
8. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ et al. (2003). NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643.
9. Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, Maher ER et al. (2002). SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 62: 5874-5880.
10. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S et al. (2000). The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97: 10002-10007.
11. Gardiol D, Kuhne C, Glaunsinger B, Lee SS, Javier R, Banks L. (1999). Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18: 5487-5496.
12. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
13. Hebner CM, Laimins LA. (2006). Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16: 83-97.
14. Huibregtse JM, Scheffner M, Howley PM. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10: 4129-4135.
15. Jiang M, Milner J. (2002). Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21: 6041-6048.
16. Kim VN. (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
17. Kohlberger P, Beneder C, Horvat R, Leodolter S, Breitenecker G. (2003). Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia. Gynecol Oncol 89: 391-394.
18. Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA. (1992). Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 11: 3045-3052.
19. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
20. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) Method. Methods 25: 402-408.
21. Manos MM, Waldman J, Zhang TY, Greer CE, Eichinger G, Schiffman MH et al. (1994). Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis 170: 1096-1099.
22. Martinez I, Wang J, Hobson KF, Ferris RL, Khan SA. (2007). Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer 43: 415-432.
23. Massimi P, Pim D, Storey A, Banks L. (1996). HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12: 2325-2330.
24. Meissner JD. (1999). Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 80: 1725-1733.
25. Munger K, Howley PM. (2002). Human papillomavirus immortalization and transformation functions. Virus Res 89: 213-228.
26. Piboonniyom SO, Duensing S, Swilling NW, Hasskarl J, Hinds PW, Munger K. (2003). Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res 63: 476-483.
27. Skyldberg B, Salo S, Eriksson E, Aspenblad U, Moberger B, Tryggvason K et al. (1999). Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 91: 1882-1887.
28. Stanley MA, Browne HM, Appleby M, Minson AC. (1989). Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 43: 672-676.
29. Tang S, Tao M, McCoy Jr JP, Zheng ZM. (2006). The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 80: 4249-4263.
30. Thomas M, Pim D, Banks L. (1999). The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18: 7690-7700.
31. Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J. (2006). Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12: 2014-2024.
32. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A et al. (2006). MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-9141.
33. zur Hausen H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.